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The SWOSU College of Pharmacy Rural Health Network,
with the Southwestern Pharmacy Foundation Continuing Education Department,
will be offering an Oklahoma State Board of Pharmacy-Approved
Immunization Training Program
on Saturday, July 16
on SWOSU campus in Weatherford, Oklahoma.
Early Registration is due by July 1.
Class size is limited,
so be sure to register early.
Here is the link
to the brochure with more details including the Registration Form:
http://www.southwesternpharmacy.com/docs/ProgramBrochure.pdf.
For more program information,
please contact Immunization Training Program Coordinator,
Randy Curry (randy.curry@swosu.edu or 580-774-3760).
Note: see attachment on SWOSU College of Pharmacy Panama Medical Mission Trip (check Facebooks for more pictures.)
RECALLS
 Hummingbird Med Devices Inc. Recalls Hummi Micro-Draw Blood Transfer Device Due to Potential for Parts to Disconnect
o http://www.fda.gov/MedicalDevices/Safety/ListofRecalls/ucm503689.htm?source=govdelivery&utm_medium=email&utm_source=
govdelivery
 FDA Drug Safety Communication: FDA warns about rare but serious skin reactions with mental health drug olanzapine (Zyprexa,




 FDA Panel Backs Approval of Sanofi Combination Diabetes Drug
o http://www.firstreportnow.com/articles/us-panel-backs-approval-sanofi-combination-diabetes-drug
 Hummingbird Med Devices Inc. Recalls Hummi Micro-Draw Blood Transfer Device Due to Potential for Parts to Disconnect
o http://www.fda.gov/MedicalDevices/Safety/ListofRecalls/ucm503689.htm?source=govdelivery&utm_medium=email&utm_source=govd
elivery
Human Drug Product Recalls Pending Classification
 http://www.fda.gov/Safety/Recalls/EnforcementReports/ucm310739.htm
Auvi-Q (epinephrine injection, USP)
Auto-Injector, 0.3 mg (a) 2 prefilled
auto injectors + 1 trainer (NDC 0025-
5833-02) and (b) 1 prefilled auto
injector + 1 trainer (NDC 0024-5833-
00), Rx Only, Manufactured for
Sanofi-Aventis US, LLC Bridgewater,
NJ 08807 A Sanofi Company
Class
I
a) 2081278, 2113841, 2113842,
2144138, exp 10/2015; 2440675, exp
04/2016; 2506456, 2506460,
2546946, 2546947, exp 05/2016;
2620206, 2620207, 2659534, exp
06/2016; 2692111, 2692112, exp
07/2016; 2716517, 2719817,
2734079, 2734080, 2734081,
2778035, 2800128, exp 08/2016;
2800130, 2824828, 2824829,
2857516, 2867928, 2870928,
Defective Delivery System; potential to







This image cannot currently be displayed.
2867929, 2867930, 2883616,
2883617, exp 09/2016; 2883618,
2883619, 2974267, 2883620, more...
Drugs
Auvi-Q (epinephrine injection, USP)
Auto-Injector, 0.15 mg (a) 2 prefilled
auto injectors + 1 trainer (NDC 0024-
5831-02) and (b) 1 prefilled auto
injector + 1 trainer (NDC 0024-5831-
00), Rx Only, Manufactured for
Sanofi-Aventis US, LLC Bridgewater,
NJ 08807 A Sanofi Company
Class
I
a) 2144144, exp 10/2015; 2469674,
exp 04/2016; 2506492, 2546978,
2546979, exp 05/2016; 2654817,
2654818, exp 06/2016; 2692143,
2692144, exp 07/2016; 2719838, exp
08/2016; 2824845, 2891021,
2857530, exp 09/2016; 2883631,
2883632, exp 10/2016; 2883633,
2945429, 3028243, exp 11/2016;
3037230, 2966680, 2974276,
2974280, exp 12/2016; and b)
2525474, exp 05/2016
Defective Delivery System; potential to








LIPO ESCULTURA capsules, 250 mg,






Marketed Without An Approved
NDA/ANDA: Tainted product marketed
as a dietary supplement. Product found
to be tainted with sibutramine, an
appetite suppressant that was
withdrawn from the U.S. market in
October 2010 for safety reasons, and
diclofenac, a prescription non-steroidal









Pink Bikini capsules, (all colors and all
strengths), packaged in 30-count
bottle, Manufactured and Distributed
by: Lucy's Weight Loss System (dba
Waisted With Lucy), Arlington, TX
76010
Class
I All lots, all colors and all strengths












Black Ant, packaged in Big Box (20
small boxes / 4 capsules per box / 80
capsules total), Distributed by: R
Class
I all lots











Black Ant, packaged in Big Box (20
small boxes / 4 capsules per box / 80
capsules total), Distributed by: R













Real Skill, packaged in 20 small boxes
/ 4 capsules per box / 80 capsules
total, Distributed by: R Thomas
Marketing, LLC, Bronx, NY 10467
SHORTAGES
June 02, 2016
 Lindane Lotion, USP 1% (Discontinuation)
May 24, 2016
 Terbinafine (Lamisil) Oral Granules (Discontinuation)
May 10, 2016
 Cyclosporine Capsules (Discontinuation)
 Imipenem and Cilastatin for Injection, USP (Discontinuation)
April 26, 2016
 Fluphenazine Tablets (Discontinuation)
April 07, 2016
 Theophylline Extended Release Tablets and Capsules (Currently in Shortage)
Updated
June 01, 2016
 Cefepime Injection (Currently in Shortage)
 Fentanyl Citrate (Sublimaze) Injection (Currently in Shortage)
 Lidocaine Hydrochloride (Xylocaine) Injection (Currently in Shortage)
 Multi-Vitamin Infusion (Adult and Pediatric) (Currently in Shortage)
 Piperacillin and Tazobactam (Zosyn) Injection (Currently in Shortage)
 Sodium Bicarbonate Injection, USP (Currently in Shortage)
 Sodium Chloride 23.4% Injection (Currently in Shortage)
May 27, 2016
 Tigecycline (Tygacil) Injection (Currently in Shortage)
May 26, 2016
 Methylprednisolone Sodium Succinate for Injection, USP (Currently in Shortage)
May 25, 2016
 Cefepime Injection (Currently in Shortage)
May 24, 2016
 Doxorubicin (Adriamycin) Injection (Currently in Shortage)
 Imipenem and Cilastatin for Injection, USP (Currently in Shortage)
 Lidocaine Hydrochloride (Xylocaine) Injection (Currently in Shortage)
 Methylprednisolone Sodium Succinate for Injection, USP (Currently in Shortage)
 Piperacillin and Tazobactam (Zosyn) Injection (Currently in Shortage)
 Potassium Chloride Injection (Currently in Shortage)
 Sodium Chloride 0.9% Injection Bags (Currently in Shortage)
 Sodium Chloride 23.4% Injection (Currently in Shortage)
 THAM Solution (Tromethamine Injection) (Discontinuation)
 Vancomycin Hydrochloride for Injection, USP (Currently in Shortage)
HIPAA
 OCR Releases New HIPAA Audit Protocol and Other Audit-Related Materials
o https://www.healthlawpolicymatters.com/2016/04/20/hhs-office-for-civil-rights-releases-new-hipaa-audit-protocol/
PHARMACIST ED & PATIENT SAFETY
 Clues to How Popular Heartburn Drug Might Harm Arteries
o https://www.nlm.nih.gov/medlineplus/news/fullstory_158754.html
 New Guidelines Recommend Prophylaxis, Antiretroviral Medications in HIV-Exposed Persons
o http://www.firstreportnow.com/articles/New-Guidelines-Recommend-Prophylaxis-Antiretroviral-Medications-HIV-Exposed-Persons
IMMUNIZATIONS
This image cannot currently be displayed.
 http://www.immunize.org/express/issue1245.asp
 Vaccines & Immunizations
o http://www.cdc.gov/vaccines/index.html
INSURANCE
· Cortisporin Otic (May 11, 2016)
· Aggrenox (May 4, 2016)
· Migranal/DHE 45 (May 4, 2016)
· Noxafil/Cresemba (April 13, 2016)
· Nuelasta/Granix/Zarxio (March 15, 2016)
· APAP/IBU/Compounded Medications (March 6, 2016)
· Tetracycline/Fluoroquinolone Update (March 2, 2016)
HOSPITAL
 Active Shooter Preparedness for Healthcare:







 Mylan launches first 200-mg Doryx generic
o http://www.drugstorenews.com/article/mylan-launches-first-00-mg-doryx-generic?tp=i-H55-Q5U-lm-ZSvM-1v-wGU-1c-Bi1-ZR8j-
29Lz59&utm_campaign=Generics&utm_source=Experian&utm_medium=email&cid=2962&mid=8452668






 Do I need to worry about my teen getting hooked on Imodium?
o http://www.univadis.com/viewarticle/do-i-need-to-worry-about-my-teen-getting-hooked-on-imodium-402909
 Hard' Tap Water Linked to Eczema in Babies
o Skin condition seems more likely in areas with high mineral content in water, study finds
o https://www.nlm.nih.gov/medlineplus/news/fullstory_159150.html
 FDA Calls for Less Salt in Processed Foods
o Agency sets short- and long-term goals in effort to cut Americans' risk of high blood pressure, heart disease, stroke
o https://www.nlm.nih.gov/medlineplus/news/fullstory_159136.html
 This content is copyright protected
 However, if you would like to share the information in this article, you may use the headline, summary and link below:
 Concealed compliance info lands ex-Ranbaxy owners $385m costs
 By Dan Stanton+, 10-May-2016
 The former owners of Indian drugmaker Ranbaxy have been ordered to pay Daiichi Sankyo $385m for concealing quality problems across its
manufacturing network before selling the business.
http://www.in-pharmatechnologist.com/Regulatory-Safety/Concealed-compliance-info-lands-ex-Ranbaxy-owners-385m-costs
